Detalhe da pesquisa
1.
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.
Cancer Immunol Immunother
; 72(11): 3461-3474, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37528320
2.
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.
Cancer Immunol Immunother
; 68(8): 1379-1389, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338557
3.
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma.
Front Immunol
; 12: 740890, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34712230
4.
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.
Clin Cancer Res
; 24(8): 1891-1904, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363526
5.
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator.
Oncoimmunology
; 5(9): e1214787, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27757311